retatrutide weight loss study VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide – The New Weight

This is the mechanism that supports its inclusion in Contrave (bupropion-naltrexone) as an FDA-approved weight loss combination

An increased antioxidant capacity manifested as enhanced antioxidant action on Nrf2 activation has been observed

GLP-1 and GIP/GLP-1 Medications: Powerful Tools for Appetite Control and Metabolic Health GLP-1 agonists and dual GIP/GLP-1 agents represent some of the most effective medical weight loss tools available today

The closer to the center a drug is, the closer to launch

Second-generation drugs are equally effective in lowering blood glucose concentrations, but there are differences in absorption, metabolism and dosing (Table I)